Public Perspectives on Women’s Health Policy Priorities for the Biden-Harris Administration and Congress February 2, 2021 Issue Brief The KFF Women’s Health Survey asked respondents how much of a priority seven key women’s health policies should be for the new President and Congress. This issue brief examines attitudes toward those policy priorities and differences by gender, political party affiliation, and demographic factors.
COVID-19 Now Leading Cause of Death in the United States February 2, 2021 Slide In January 2021, the number of deaths from COVID-19 increased so rapidly that it has clearly become the number one cause of death in the U.S., with an average of more than 3,000 people per day dying of COVID-19 in the U.S. as of Jan. 26. Learn more in this Chart of the Week from the Peterson-KFF Health System Tracker.
This Week in Coronavirus: January 22 to January 28 January 29, 2021 Blog During the 53rd week since the first coronavirus case appeared in the United States, the world surpassed 100 million COVID-19 cases, with the United States accounting for a quarter of them. The U.S. also accounts for one-fifth (433,200) of the world’s nearly 2.2 million reported deaths.
How Can Trump Administration Regulations Be Reversed? January 29, 2021 Issue Brief With the inauguration of President Biden and Democrats holding a slim majority in Congress, policymakers are likely to consider whether and how to reverse various health policy regulations issued by the Trump Administration.
The Mexico City Policy: An Explainer January 28, 2021 Fact Sheet An overview of the Mexico City Policy, which, when last in effect, required foreign NGOs to certify that they would not “perform or actively promote abortion as a method of family planning” using funds from any source (including non-U.S. funds) as a condition for receiving most U.S. government global health assistance.
Analyzing Recent Trends in Medicaid/CHIP Applications: What We Do and Do Not Know January 28, 2021 Issue Brief This data note discusses changes in the number of applications for Medicaid/CHIP coverage during the coronavirus pandemic. Although enrollment in Medicaid/CHIP has increased steadily by more than 6 million individuals (9%) from February to September 2020, the total number of Medicaid/CHIP applications has decreased by more than 150,000 (-6%) in the same time period. The decline in applications might on the surface suggest that fewer people are applying for coverage even in the face of large job and income losses, but data limitations – in particular, the fact that application statistics do not distinguish between new signups and renewals – make it difficult to draw any clear conclusions.
Addressing the Risk of Medicare Trust Fund Insolvency January 27, 2021 Perspective In this Viewpoint for the Journal of the American Medical Association (JAMA), KFF’s Tricia Neuman and co-author Richard G. Frank of Harvard Medical School explain that the looming 2024 insolvency of the Medicare Hospital Insurance Trust Fund cannot be ignored for long.
Nearly 9 Million Uninsured Americans Could Get Free or Subsidized Health Insurance if the Biden Administration Re-Opens ACA Marketplace Enrollment in Response to COVID-19 January 27, 2021 News Release Four million uninsured people could get an ACA bronze plan with no premium payment and 4.9 million others could get subsidies to offset the cost of such a plan if the Biden Administration were to re-open ACA marketplace enrollment, a KFF analysis finds. Four million uninsured people could get an…
Vaccine Monitor: Nearly Half of the Public Wants to Get a COVID-19 Vaccine as Soon as They Can or Has Already Been Vaccinated, Up across Racial and Ethnic Groups Since December January 27, 2021 News Release Most Convincing Messages to Promote Vaccination Highlight Effectiveness at Preventing Illness and a Return to Normal Life; Hearing about Rare Allergic Reactions and Side Effects May Discourage Some New KFF Dashboard Features Key Data and Insights from the Vaccine Monitor With millions of Americans getting their first COVID-19 vaccinations, the…
Racial Diversity within COVID-19 Vaccine Clinical Trials: Key Questions and Answers January 26, 2021 Issue Brief This brief reviews why racial diversity within COVID-19 vaccine clinical trials is important, discusses the barriers to participation in clinical trials among people of color, and examines the racial/ethnic composition of clinical trial participants for the Pfizer-BioNTech and Moderna vaccines.